Akhil Suresh

776 total citations
20 papers, 532 citations indexed

About

Akhil Suresh is a scholar working on Pharmaceutical Science, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Akhil Suresh has authored 20 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Infectious Diseases and 5 papers in Computational Theory and Mathematics. Recurrent topics in Akhil Suresh's work include Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Advancements in Transdermal Drug Delivery (4 papers). Akhil Suresh is often cited by papers focused on Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Advancements in Transdermal Drug Delivery (4 papers). Akhil Suresh collaborates with scholars based in India, Australia and Canada. Akhil Suresh's co-authors include Usha Y. Nayak, Yogendra Nayak, Chetan Hasmukh Mehta, Madhukar Rai, Shyam Sundar, Shri Prakash Singh, Henry W. Murray, Reema Narayan, Swastika Maity and Swapnil Mehta and has published in prestigious journals such as Clinical Infectious Diseases, Coordination Chemistry Reviews and Carbohydrate Polymers.

In The Last Decade

Akhil Suresh

20 papers receiving 517 citations

Peers

Akhil Suresh

PHEOH

BIOMA

CTM

Cristina Donini Switzerland

Viney Chawla India

Ana Gomes Portugal

Matshawandile Tukulula South Africa

Jairam Meena India

Sharon A. Creason United States

Jay Prakash Jain India

Subhasish Mondal India

Mohammad Yousuf Ansari India

P.C Sathler Brazil

Cristina Donini Switzerland

Akhil Suresh

116 ×0.7

PHEOH

56 ×0.5

56 ×0.6

BIOMA

58 ×0.7

CTM

67 ×0.8

Citations per year, relative to Akhil Suresh Akhil Suresh (= 1×) peers Cristina Donini

Countries citing papers authored by Akhil Suresh

Since Specialization

Citations

This map shows the geographic impact of Akhil Suresh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhil Suresh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhil Suresh more than expected).

Fields of papers citing papers by Akhil Suresh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akhil Suresh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhil Suresh. The network helps show where Akhil Suresh may publish in the future.

Co-authorship network of co-authors of Akhil Suresh

This figure shows the co-authorship network connecting the top 25 collaborators of Akhil Suresh. A scholar is included among the top collaborators of Akhil Suresh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akhil Suresh. Akhil Suresh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suresh, Akhil, et al.. (2023). Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses. 15(1). 213–213. 2 indexed citations

Mehta, Chetan Hasmukh, et al.. (2023). Controlled Release Technologies for Chronotherapy: Current Status and FuturePerspectives. Current Pharmaceutical Design. 29(14). 1069–1091. 4 indexed citations

Suresh, Akhil, et al.. (2022). Antibacterial Coating on Filtration Membranes for Treatment of Cutting Fluid. International Journal for Research in Applied Science and Engineering Technology. 10(12). 827–830. 1 indexed citations

Suresh, Akhil, et al.. (2022). Enhancing the oral bioavailability of asenapine maleate with bio-enhancer: An in-silico assisted in-vivo pharmacokinetic study. Journal of Drug Delivery Science and Technology. 70. 103215–103215. 2 indexed citations

Mehta, Swapnil, Akhil Suresh, Yogendra Nayak, Reema Narayan, & Usha Y. Nayak. (2022). Hybrid nanostructures: Versatile systems for biomedical applications. Coordination Chemistry Reviews. 460. 214482–214482. 52 indexed citations

Suresh, Akhil, et al.. (2021). Advances and challenges in nintedanib drug delivery. Expert Opinion on Drug Delivery. 18(11). 1687–1706. 9 indexed citations

Narayan, Reema, Shivaprasad Gadag, Sri Pragnya Cheruku, et al.. (2021). Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy. Carbohydrate Polymers. 261. 117893–117893. 71 indexed citations

Maity, Swastika, et al.. (2021). SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study. European Journal of Pharmacology. 896. 173922–173922. 33 indexed citations

Singh, Yash Pal, Akhil Suresh, Gourav Singh, et al.. (2021). Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19. Molecular Diversity. 25(3). 1905–1927. 48 indexed citations

10.

Rodrigues, Fiona Concy, K. Sreedhara Ranganath Pai, Akhil Suresh, et al.. (2021). Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer. 3 Biotech. 11(12). 506–506. 10 indexed citations

11.

Mehta, Chetan Hasmukh, et al.. (2021). Development of lapatinib nanosponges for enhancing bioavailability. Journal of Drug Delivery Science and Technology. 65. 102684–102684. 30 indexed citations

12.

Maity, Swastika, et al.. (2020). Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study. Archives of Medical Research. 52(1). 38–47. 47 indexed citations

13.

Suresh, Akhil, et al.. (2020). Assessing the behavior management problems during the first dental visit of preschool children using a doll placement test. Journal of Indian Society of Pedodontics and Preventive Dentistry. 38(1). 41–41. 2 indexed citations

14.

Maity, Swastika, et al.. (2020). In Silico Drug Repurposing of Penicillins to Target Main Protease M^proof SARS-CoV-2. Pharmaceutical Sciences. 26(Covid-19). S52–S62. 4 indexed citations

15.

Suresh, Akhil, Reema Narayan, & Usha Y. Nayak. (2020). Recent advances in the development of asenapine formulations. Expert Opinion on Drug Delivery. 17(10). 1377–1393. 9 indexed citations

16.

Suresh, Akhil, et al.. (2018). DEVELOPMENT AND IN VITRO EVALUATION OF NANOLIPID CARRIERS OF CLOBETASOL PROPIONATE AND PRAMOXINE HYDROCHLORIDE FOR TOPICAL DELIVERY. International Journal of Applied Pharmaceutics. 28–36. 7 indexed citations

17.

Suresh, Akhil, et al.. (2018). Sustained release timolol maleate loaded ocusert based on biopolymer composite. International Journal of Biological Macromolecules. 110. 308–317. 18 indexed citations

18.

Suresh, Akhil, et al.. (2018). Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis. Advanced Pharmaceutical Bulletin. 8(2). 257–265. 25 indexed citations

19.

Suresh, Akhil, et al.. (2017). Peltier integrated heating & cooling jacket. 2017 International conference of Electronics, Communication and Aerospace Technology (ICECA). 2. 260–263. 9 indexed citations

20.

Sundar, Shyam, et al.. (2004). Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations. Clinical Infectious Diseases. 38(3). 377–383. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact